AMP Capital Investors Ltd raised its holdings in shares of Davita Inc (NYSE:DVA) by 47.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,499 shares of the company’s stock after acquiring an additional 21,414 shares during the period. AMP Capital Investors Ltd’s holdings in Davita were worth $4,738,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in DVA. United Asset Strategies Inc. increased its position in shares of Davita by 13.0% during the 2nd quarter. United Asset Strategies Inc. now owns 6,405 shares of the company’s stock valued at $445,000 after purchasing an additional 735 shares during the period. Commonwealth Equity Services LLC increased its position in shares of Davita by 10.2% during the 3rd quarter. Commonwealth Equity Services LLC now owns 8,168 shares of the company’s stock valued at $585,000 after purchasing an additional 757 shares during the period. Northstar Group Inc. increased its position in shares of Davita by 7.8% during the 3rd quarter. Northstar Group Inc. now owns 11,684 shares of the company’s stock valued at $837,000 after purchasing an additional 850 shares during the period. Vident Investment Advisory LLC increased its position in shares of Davita by 1.5% during the 2nd quarter. Vident Investment Advisory LLC now owns 57,294 shares of the company’s stock valued at $3,979,000 after purchasing an additional 872 shares during the period. Finally, IFM Investors Pty Ltd increased its position in shares of Davita by 13.0% during the 3rd quarter. IFM Investors Pty Ltd now owns 7,958 shares of the company’s stock valued at $570,000 after purchasing an additional 915 shares during the period. 85.76% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NYSE DVA opened at $58.96 on Monday. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.82 and a current ratio of 1.84. The firm has a market capitalization of $9.79 billion, a P/E ratio of 17.76, a P/E/G ratio of 0.78 and a beta of 1.07. Davita Inc has a 52-week low of $58.65 and a 52-week high of $80.71.
Davita (NYSE:DVA) last issued its earnings results on Wednesday, November 7th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.89 by ($0.33). The company had revenue of $2.85 billion during the quarter, compared to analyst estimates of $2.93 billion. Davita had a return on equity of 13.87% and a net margin of 5.39%. The business’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.81 earnings per share. As a group, research analysts expect that Davita Inc will post 3.56 EPS for the current fiscal year.
DVA has been the topic of several research analyst reports. JPMorgan Chase & Co. upgraded Davita from an “underweight” rating to a “neutral” rating in a research report on Thursday, September 13th. Zacks Investment Research upgraded Davita from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research report on Monday, October 8th. ValuEngine upgraded Davita from a “hold” rating to a “buy” rating in a research report on Tuesday, October 9th. Raymond James cut Davita from a “strong-buy” rating to a “market perform” rating in a research report on Thursday, November 8th. Finally, Royal Bank of Canada lifted their price target on Davita from $70.00 to $78.00 and gave the company a “sector perform” rating in a research report on Thursday, November 8th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $79.68.
WARNING: This piece was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/12/10/davita-inc-dva-holdings-increased-by-amp-capital-investors-ltd.html.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading: Average Daily Trade Volume Explained
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.